[Elsevier] [Supplementary]Efficacy and safety of once-weekly tirzepatide in Japanese patients with obesity disease (SURMOUNT-J): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

augustint Post time Half hour(s) ago | Show all posts |Read mode

This post will be closed automatically in 2026-09-25 03:43

Reward10points

Clinical Trial
Lancet Diabetes Endocrinol

. 2025 May;13(5):384-396.
doi: 10.1016/S2213-8587(24)00377-2. Epub 2025 Feb 28.
Efficacy and safety of once-weekly tirzepatide in Japanese patients with obesity disease (SURMOUNT-J): a multicentre, randomised, double-blind, placebo-controlled phase 3 trialTakashi Kadowaki 1, Arihiro Kiyosue 2, Tomotaka Shingaki 3, Tomonori Oura 4, Koutaro Yokote 5

You can support us by donating, we would be very grateful.

Reply

Use magic Donate Report